Literature DB >> 25360497

Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes.

David Z I Cherney1, Bruce A Perkins2, Nima Soleymanlou3, Fengxia Xiao4, Joseph Zimpelmann4, Hans-Juergen Woerle5, Odd E Johansen6, Uli C Broedl5, Maximilian von Eynatten7, Kevin D Burns4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25360497     DOI： 10.1038/ki.2014.246

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  36 in total

Review 1.  Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA.

Authors:  Dorrin Zarrin Khat; Mansoor Husain
Journal:  Curr Diab Rep       Date:  2018-06-09       Impact factor: 4.810

Review 2.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

3.  Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus.

Authors:  Chantal Kopecky; Yuliya Lytvyn; Oliver Domenig; Marlies Antlanger; Johannes J Kovarik; Christopher C Kaltenecker; Marko Poglitsch; Bruce A Perkins; Kerry-Anne Rye; David Z I Cherney; Marcus D Säemann
Journal:  Diabetologia       Date:  2019-04-11       Impact factor: 10.122

Review 4.  The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure.

Authors:  Merlin C Thomas; David Z I Cherney
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 5.  Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

Authors:  David León Jiménez; David Z I Cherney; Petter Bjornstad; Luis Castilla-Guerra; José Pablo Miramontes González
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

6.  Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study.

Authors:  Harindra Rajasekeran; Heather N Reich; Michelle A Hladunewich; Daniel Cattran; Julie A Lovshin; Yuliya Lytvyn; Petter Bjornstad; Vesta Lai; Josephine Tse; Leslie Cham; Syamantak Majumder; Bridgit B Bowskill; M Golam Kabir; Suzanne L Advani; Ian W Gibson; Manish M Sood; Andrew Advani; David Z I Cherney
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-15

7.  Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Di Zhao; Hui Liu; Pingshuan Dong
Journal:  J Hum Hypertens       Date:  2018-11-15       Impact factor: 3.012

8.  Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Authors:  Julie A Lovshin; Geneviève Boulet; Yuliya Lytvyn; Leif E Lovblom; Petter Bjornstad; Mohammed A Farooqi; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Zi Cherney
Journal:  JCI Insight       Date:  2018-01-11

Review 9.  Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney
Journal:  Circulation       Date:  2017-10-24       Impact factor: 29.690

Review 10.  The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Daniel H van Raalte; Hiddo L Heerspink; David Z I Cherney
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.